Second, implementing dietary interventions to assess the impact of modifying dietary insulin indices on metabolic outcomes in individuals with T2DM and finally, conducting mechanistic studies to elucidate the biological pathways through which dietary insulin indices influence insulin resistance, abdominal obesity, and other cardiometabolic risk factors. This evidence concerns the gene INS and Abdominal obesity.